NovoCure Ltd
NVCR· Nasdaq
NVCRNovoCure Ltd
Source filing unavailable
| Metric | Q2 2016 | Q2 2015 |
|---|---|---|
| Revenue | $17.92M | $6.54M |
| Net Income | -$40.61M | -$29.36M |
| EPS Diluted | -$0.48 | -$2.36 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NovoCure Ltd · CIK 1645113 · Engraved from SEC EDGAR
